- From: joshua phillips <joshua.phillips@semanticbits.com>
- Date: Tue, 17 Nov 2009 13:34:24 -0500
- To: "Marshall, M.S." <marshall@science.uva.nl>
- Cc: public-semweb-lifesci@w3.org
- Message-ID: <b4ec689c0911171034k42214cfbj6168896f229367a3@mail.gmail.com>
Hi Scott, I'd be happy to discuss some ideas in an HCLS telecon. Unfortunately, the 26th is a holiday in the U.S. December 1st would work for me. - Joshua On Tue, Nov 17, 2009 at 10:36 AM, Marshall, M.S. <S.Marshall@uva.nl> wrote: > Hi Joshua, > > I suspect that the impending COI demonstration (10:30AM) at AMIA in San > Francisco in a few hours would explain why you haven't received an > answer yet from some of the COI people. Eric Prud'hommeaux and Helen > Chen (AGFA) and others (Holger?) have been looking at injecting security > policy > at the SPARQL endpoint as an extensional feature for the COI scenario. > We already have a use case for this in Terminology as well. > > I am sure that others would be interested in hearing more about how COI > (and other work such as BioRDF) relate to caBIG such as with > the applications that you mentioned. Maybe we could talk about it in a > teleconference. I know that the normal slot for HCLS telcon (11AM EST) > on Nov. 26 is now open. Would you have time to talk about it then? I > would be interested in learning more about the caBIG applications and > where the potential overlaps are. > > Best, > Scott > > > joshua phillips wrote: > > Hi, > > > > What are the next steps for the Clinical Observations Interop group? Are > you > > looking for new use cases and data sets to work with? I'm interested to > > explore how this work could be applied to data from applications > developed > > in caBIG such as caTissue (biospecimen annotations), caArray (gene > > expression), caAERS (adverse events), and C3PR (eligibility criteria, > > patient registration, protocols). > > > > - Joshua > > > > > > > >
Received on Tuesday, 17 November 2009 18:34:56 UTC